Abstract
Tuberculosis is one of the leading causes of morbidity and mortality worldwide. Current treatment has several challenges, such as multi-drug resistance, extensively drug-resistance and HIV co-infection. Problems related to patients, treatment and health care system also contribute negatively to this panel. This review summarizes the main obstacles causing in the treatment of tuberculosis and discusses several strategies to improve the treatment.
Keywords: Drug interactions, extensively drug-resistance, HIV, multi-drug resistance, treatment improvement, tuberculosis, tuberculosis treatment.
Current Clinical Pharmacology
Title:Tuberculosis: Challenges to Improve the Treatment
Volume: 10 Issue: 3
Author(s): Mariana Moreira Lima, Ariane Trindade, Flávia Carnavalli, Aylime Castanho Bolognesi Melchior, Chung Man Chin and Jean Leandro dos Santos
Affiliation:
Keywords: Drug interactions, extensively drug-resistance, HIV, multi-drug resistance, treatment improvement, tuberculosis, tuberculosis treatment.
Abstract: Tuberculosis is one of the leading causes of morbidity and mortality worldwide. Current treatment has several challenges, such as multi-drug resistance, extensively drug-resistance and HIV co-infection. Problems related to patients, treatment and health care system also contribute negatively to this panel. This review summarizes the main obstacles causing in the treatment of tuberculosis and discusses several strategies to improve the treatment.
Export Options
About this article
Cite this article as:
Lima Moreira Mariana, Trindade Ariane, Carnavalli Flávia, Bolognesi Melchior Castanho Aylime, Chin Man Chung and dos Santos Leandro Jean, Tuberculosis: Challenges to Improve the Treatment, Current Clinical Pharmacology 2015; 10 (3) . https://dx.doi.org/10.2174/1574884708666131229124215
DOI https://dx.doi.org/10.2174/1574884708666131229124215 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Impact of Structural Domains of the Heparin Binding Hemagglutinin of Mycobacterium tuberculosis on Function
Protein & Peptide Letters Dendritic Cells in Innate Immune Responses Against HIV
Current Molecular Medicine Novel Concepts for Anti-Infective Activity of Cytokines, Chemokines and Diverse Agents
Recent Patents on Anti-Infective Drug Discovery Interleukin 10 in Antiviral Responses
Current Immunology Reviews (Discontinued) Editorial [Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)]
Current Pharmacogenomics and Personalized Medicine Targeted Anti Bacterial Therapy
Infectious Disorders - Drug Targets 3D-QSAR Approaches in Drug Design: Perspectives to Generate Reliable CoMFA Models
Current Computer-Aided Drug Design Exploiting Innate γδ T Lymphocytes for Tumor Immunotherapy
Recent Patents on Biomarkers Chemotherapeutic Strategies Against Trypanosoma brucei: Drug Targets vs. Drug Targeting
Current Pharmaceutical Design Discovery of New Potential Antimalarial Compounds Using Virtual Screening of ZINC Database
Combinatorial Chemistry & High Throughput Screening Evaluation of Small Molecule Tuberculostats for Targeting Tuberculosis Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry The Changing Face of Tobacco Use Among United States Youth
Current Drug Abuse Reviews Understanding the Molecular Mechanisms of Rifaximin in the Treatment of Gastrointestinal Disorders – A Focus on the Modulation of Host Tissue Function
Mini-Reviews in Medicinal Chemistry Alkaptonuria, Ochronosis and Ochronotic Arthropathy in Mainland France and the Reunion Island. A Report of Clinical and Molecular Findings in 29 Patients
Current Rheumatology Reviews BM 212 and its Derivatives as a New Class of Antimycobacterial Active Agents
Current Medicinal Chemistry Alterations in the Vascular Reactivity of Aorta in the Early and Late Phase of Adjuvant-Induced Arthritis in Rat
Vascular Disease Prevention (Discontinued) Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism Novel Applications of Nanotechnology in Controlling HIV and HSV Infections
Current Drug Research Reviews Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis
Current Molecular Pharmacology Two Neglected Multicomponent Reactions: Asinger and Groebke Reaction for Constructing Thiazolines and Imidazolines
Current Organic Synthesis